Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28371330 | 0.98 | ACHE (0.44) | ACHEL3MBTL1KMT2AALDH1A1GAA | |
| SCHEMBL27920269 | 0.89 | KDM4E (0.47) | L3MBTL1KMT2AALDH1A1GAAHSD17B10 | |
| SCHEMBL28375363 | 0.88 | KDM4E (0.46) | L3MBTL1KMT2AALDH1A1GAAHSD17B10 | |
| SCHEMBL28371448 | 0.85 | KDM4E (0.57) | L3MBTL1KMT2AALDH1A1GAAHSD17B10 | |
| SCHEMBL448000 | 0.85 | ALDH1A1 (0.60) | L3MBTL1KMT2AALDH1A1GAAHSD17B10 | |
| SCHEMBL29609999 | 0.85 | ALDH1A1 (0.60) | L3MBTL1KMT2AALDH1A1GAAHSD17B10 | |
| SCHEMBL28375346 | 0.84 | ALOX15 (0.46) | L3MBTL1KMT2AALDH1A1GAAHSD17B10 | |
| SCHEMBL28324766 | 0.84 | ALDH1A1 (0.44) | L3MBTL1KMT2AALDH1A1GAAHSD17B10 | |
| SCHEMBL9561631 | 0.84 | KMT2A (0.52) | KMT2AALDH1A1MAPK1KDM4ERAB9A | |
| SCHEMBL28376629 | 0.84 | KDM4E (0.56) | L3MBTL1KMT2AKDM4EMEN1PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103450714-B | A kind of conductive graphite flake and preparation method thereof | TORAY ADVANCED MATERIALS RESEARCH LABORATORIES (CHINA) CO., LTD. (CN) | 2015-11-25 | — | — | CN | claimed |
| CN-103450714-A | Conductive graphite flake and preparation method thereof | TORAY ADVANCED MATERIALS RES LAB CHINA CO LTD | 2013-12-18 | — | — | CN | claimed |
| EP-4707308-A2 | PREGABALIN IMMUNOASSAYS | ARK Diagnostics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-3761036-B1 | PREGABALIN IMMUNOASSAYS | ARK DIAGNOSTICS INC (US) | 2025-11-19 | — | — | EP | disclosed |
| US-12203938-B2 | Levetiracetam immunoassays | ARK DIAGNOSTICS, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-20240192236-A1 | Compounds and Methods for Use in Detecting Gabapentin | ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT | 2024-06-13 | — | — | US | disclosed |
| CN-111413849-B | Photosensitive composition, preparation method thereof, pattern forming method and application | 常州强力先端电子材料有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-11867705-B2 | Compounds and methods for use in detecting gabapentin | ARK DIAGNOSTICS, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| US-20230417779-A1 | Pregabalin Immunoassays | ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT | 2023-12-28 | — | — | US | disclosed |
| CN-114207043-B | Composition for producing siliceous film having low dielectric constant and method for producing cured film and electronic device using the same | 默克专利有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-109471330-B | Photosensitive composition and photopolymerization initiator used therein | 东京应化工业株式会社 | 2023-08-29 | — | — | CN | disclosed |
| US-20070218486-A1 | Immunoassays, Haptens, Immunogens and Antibodies for Anti-HIV Therapeutics | ARK DIAGNOSTICS, INC. (US) | 2007-09-20 | — | — | US | disclosed |
| WO-2007103740-A2 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | ARK DIAGNOSTICS (US) | 2007-09-13 | — | — | WO | disclosed |
| EP-1700122-A2 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | ARK DIAGNOSTICS (US) | 2006-09-13 | — | — | EP | disclosed |
| US-20050244816-A1 | Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics | ARK DIAGNOSTICS, INC. (US) | 2005-11-03 | — | — | US | disclosed |
| WO-2005062979-A2 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | ARK DIAGNOSTICS (US) | 2005-07-14 | — | — | WO | disclosed |
| US-20030031655-A1 | Methods of light activated release of ligands from endosomes | SEQUITUR, INC. (US) | 2003-02-13 | — | — | US | disclosed |
| WO-2002062989-A2 | METHODS OF LIGHT ACTIVATED RELEASE 0F LIGANDS FROM ENDOSOMES | SEQUITUR, INC. (US) | 2002-08-15 | — | — | WO | disclosed |
| US-4923819-A | Time-resolved fluorescence immunoassay | CHIMERIX CORPORATION (US) | 1990-05-08 | — | — | US | disclosed |
| WO-1988007670-A2 | TIME-RESOLVED FLUORESCENCE APPARATUS AND IMMUNOASSAY | CHIMERIX CORPORATION (US) | 1988-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030031655-A1 | Methods of light activated release of ligands from endosomes | LAMP2, PLAUR, CLTB | ACHE 3141/4885L3MBTL1 2218/4885KMT2A 4666/4885 |
| US-20240192236-A1 | Compounds and Methods for Use in Detecting Gabapentin | GABRE, GABRG3, GABRB2 | ACHE 344/4885L3MBTL1 2188/4885KMT2A 4771/4885 |
| US-12203938-B2 | Levetiracetam immunoassays | GABRG1, GABRA6, LY96 | ACHE 101/4885L3MBTL1 1773/4885KMT2A 1674/4885 |
| US-20230417779-A1 | Pregabalin Immunoassays | GABRG3, GABRG1, GABRB2 | ACHE 465/4885L3MBTL1 3726/4885KMT2A 4651/4885 |
| US-11867705-B2 | Compounds and methods for use in detecting gabapentin | GABRE, GABRG3, GABRB2 | ACHE 344/4885L3MBTL1 2188/4885KMT2A 4771/4885 |
| US-20050244816-A1 | Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics | CD4, MPI, ME1 | ACHE 663/4885L3MBTL1 2680/4885KMT2A 893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.